4//SEC Filing
JACOB LEONARD S 4
Accession 0001209191-19-060111
CIK 0001016169other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 7:21 PM ET
Size
15.5 KB
Accession
0001209191-19-060111
Insider Transaction Report
Form 4
JACOB LEONARD S
Director
Transactions
- Exercise/Conversion
Common Stock
2019-12-09$1.60/sh+80,000$128,000→ 377,563 total - Sale
Common Stock
2019-12-09$4.63/sh−80,000$370,536→ 297,563 total - Sale
Common Stock
2019-12-09$4.63/sh−84,814$392,833→ 212,749 total - Exercise/Conversion
Stock Option (right to buy)
2019-12-09−80,000→ 0 totalExercise: $1.60From: 2011-05-27Exp: 2020-05-26→ Common Stock (80,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-12-09−80,000→ 0 totalExercise: $1.66From: 2012-05-17Exp: 2021-05-16→ Common Stock (80,000 underlying) - Exercise/Conversion
Common Stock
2019-12-09$1.66/sh+80,000$132,800→ 377,563 total - Sale
Common Stock
2019-12-09$4.62/sh−80,000$369,776→ 297,563 total
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0001049713
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 7:21 PM ET
- Size
- 15.5 KB